ZimVie rises on FDA nod for new version of cervical disc implant
** Shares of medtech co ZimVie Inc ZIMV.O rise 1.68% to
$12.13 premarket
** U.S. FDA approves a smaller height of its Mobi-C
artificial cervical disc implant in seven footprints
** Footprint is the part of the disk prosthesis designed to
cover the endplate of the vertebra
** Up to last close, stock up ~28% this year
(Reporting by Sriparna Roy in Bengaluru)
((Sriparna.Roy@thomsonreuters.com;))
Recent news on Zimvie
See all newsBrief: ZimVie Announces Completion of its Acquisition by ARCHIMED
Brief: ZimVie Stockholders Vote To Approve Acquisition By Archimed
ZimVie Inc reports results for the quarter ended June 30 - Earnings Summary
Brief: ZimVie Q2 Adjusted EPS USD 0.26
ZimVie Inc expected to post earnings of 21 cents a share - Earnings Preview